Capital International Investors
Position in BMY — Bristol Myers Squibb Co
CIK 1562230
Los Angeles, CA
Position in BMY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$511,427,789
-$620,855,177 QoQ
Shares Held
8,432,445
-59.8% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 99.80129132179339.ToString("F0")%
Shared 0.ToString("F0")%
None 0.19870867820661742.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International Investors holds $19,740,296,250 across 8 Drug Manufacturers - General names. BMY ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
34,393,013 | $6,782,990,023 | |
| 2 | LLY |
ELI LILLY & Co
|
6,116,692 | $5,625,949,800 | |
| 3 | ABBV |
AbbVie Inc.
|
14,418,993 | $3,135,986,787 | |
| 4 | AMGN |
Amgen Inc
|
7,122,275 | $2,505,972,458 | |
| 5 | JNJ |
Johnson & Johnson
|
2,617,363 | $639,788,211 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
8,432,445 | $511,427,789 | |
| 7 | NVO |
Novo Nordisk A S
|
11,795,850 | $433,497,487 | |
| 8 | MRK |
Merck & Co., Inc.
|
870,261 | $104,683,695 |
All Filings in BMY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $511,427,789 | 8,432,445 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,132,282,966 | 20,991,527 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,460,654,782 | 32,387,024 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,062,658,977 | 66,162,432 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,053,747,495 | 66,465,773 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,594,216,253 | 45,866,624 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,206,595,050 | 42,647,759 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,301,035,765 | 55,406,592 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,807,152,833 | 70,203,814 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,157,026,924 | 61,528,492 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,029,132,737 | 69,419,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,431,479,583 | 69,296,006 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,256,824,260 | 61,417,173 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,792,990,812 | 52,717,037 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,724,862,350 | 52,396,432 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,933,539,224 | 38,097,912 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,672,454,990 | 22,900,931 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||